Status:

COMPLETED

A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE)

Lead Sponsor:

Biosense Webster, Inc.

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The primary objective is to demonstrate safety and long-term effectiveness of the irreversible electroporation (IRE) system (Circular IRE Catheter and IRE Generator) when used for isolation of the atr...

Eligibility Criteria

Inclusion

  • Diagnosed with Symptomatic paroxysmal atrial fibrillation (PAF)
  • Selected for atrial fibrillation (AF) ablation procedure by pulmonary vein isolation (PVI)
  • Failed at least one antiarrhythmic drug (AAD) (class I to IV) as evidenced by recurrent symptomatic atrial fibrillation AF, or intolerable or contraindicated to the AAD
  • Willing and capable of providing consent
  • Able and willing to comply with all pre-, post- and follow-up testing and requirements

Exclusion

  • AF secondary to electrolyte imbalance, thyroid disease, or reversible or non-cardiac cause
  • Previous left atrium (LA) ablation or surgery
  • Participant known to require ablation outside the PV region (example. cavotricuspid isthmus \[CTI\] region, atrioventricular reentrant tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia, ventricular tachycardia and Wolff-Parkinson-White)
  • Previously diagnosed with persistent AF (greater than \[\>\] 7 days in duration)
  • Severe dilatation of the LA (LAD \>50 millimeter (mm) antero-posterior diameter in case of transthoracic echocardiography (TTE))

Key Trial Info

Start Date :

August 23 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 9 2023

Estimated Enrollment :

272 Patients enrolled

Trial Details

Trial ID

NCT04524364

Start Date

August 23 2020

End Date

May 9 2023

Last Update

May 25 2025

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Medical University Graz

Graz, Austria, 8036

2

Ordensklinikum Linz Elisabethinen

Linz, Austria, 4020

3

OLV Aalst

Aalst, Belgium, 9300

4

AZ Sint-Jan Brugge

Bruges, Belgium, 8000

A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE) | DecenTrialz